Global Peripheral Artery Angioplasty 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04255083

Publication Date:

April 9, 2025

Pages:

114

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Peripheral Artery Angioplasty market size is predicted to grow from US$ 5477 million in 2025 to US$ 10650 million in 2031; it is expected to grow at a CAGR of 11.7% from 2025 to 2031.
Major manufacturers located in United States. And many Chinese manufacturers enter into the market in recent years.
The 鈥淧eripheral Artery Angioplasty Industry Forecast鈥� looks at past sales and reviews total world Peripheral Artery Angioplasty sales in 2024, providing a comprehensive analysis by region and market sector of projected Peripheral Artery Angioplasty sales for 2025 through 2031. With Peripheral Artery Angioplasty sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Artery Angioplasty industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Artery Angioplasty landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peripheral Artery Angioplasty portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Peripheral Artery Angioplasty market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Artery Angioplasty and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Artery Angioplasty.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Artery Angioplasty market by product type, application, key players and key regions and countries.
Segmentation by Type:
Balloon Angioplasty
Stent Implantation
Segmentation by Application:
Lower Limbs
Renal Artery
Carotid Artery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic, Inc.
BD
Boston Scientific Corporation
Abbott Laboratories
Cordis
Acotec
Biotronik
Terumo Corporation
Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd.
Cook Medical
Lepu Medical
Zylox-Tonbridge Medical Technology Co., Ltd.
LeoMed
LifeTech Scientific Corporation

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Peripheral Artery Angioplasty 麻豆原创 Size (2020-2031)
2.1.2 Peripheral Artery Angioplasty 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Peripheral Artery Angioplasty by Country/Region (2020, 2024 & 2031)
2.2 Peripheral Artery Angioplasty Segment by Type
2.2.1 Balloon Angioplasty
2.2.2 Stent Implantation
2.3 Peripheral Artery Angioplasty 麻豆原创 Size by Type
2.3.1 Peripheral Artery Angioplasty 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Peripheral Artery Angioplasty 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Peripheral Artery Angioplasty Segment by Application
2.4.1 Lower Limbs
2.4.2 Renal Artery
2.4.3 Carotid Artery
2.5 Peripheral Artery Angioplasty 麻豆原创 Size by Application
2.5.1 Peripheral Artery Angioplasty 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Peripheral Artery Angioplasty 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Peripheral Artery Angioplasty 麻豆原创 Size by Player
3.1 Peripheral Artery Angioplasty 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Peripheral Artery Angioplasty Revenue by Player (2020-2025)
3.1.2 Global Peripheral Artery Angioplasty Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Peripheral Artery Angioplasty Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peripheral Artery Angioplasty by Region
4.1 Peripheral Artery Angioplasty 麻豆原创 Size by Region (2020-2025)
4.2 Global Peripheral Artery Angioplasty Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peripheral Artery Angioplasty 麻豆原创 Size Growth (2020-2025)
4.4 APAC Peripheral Artery Angioplasty 麻豆原创 Size Growth (2020-2025)
4.5 Europe Peripheral Artery Angioplasty 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Peripheral Artery Angioplasty 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Peripheral Artery Angioplasty 麻豆原创 Size by Country (2020-2025)
5.2 Americas Peripheral Artery Angioplasty 麻豆原创 Size by Type (2020-2025)
5.3 Americas Peripheral Artery Angioplasty 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Artery Angioplasty 麻豆原创 Size by Region (2020-2025)
6.2 APAC Peripheral Artery Angioplasty 麻豆原创 Size by Type (2020-2025)
6.3 APAC Peripheral Artery Angioplasty 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peripheral Artery Angioplasty 麻豆原创 Size by Country (2020-2025)
7.2 Europe Peripheral Artery Angioplasty 麻豆原创 Size by Type (2020-2025)
7.3 Europe Peripheral Artery Angioplasty 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peripheral Artery Angioplasty by Region (2020-2025)
8.2 Middle East & Africa Peripheral Artery Angioplasty 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Peripheral Artery Angioplasty 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Peripheral Artery Angioplasty 麻豆原创 Forecast
10.1 Global Peripheral Artery Angioplasty Forecast by Region (2026-2031)
10.1.1 Global Peripheral Artery Angioplasty Forecast by Region (2026-2031)
10.1.2 Americas Peripheral Artery Angioplasty Forecast
10.1.3 APAC Peripheral Artery Angioplasty Forecast
10.1.4 Europe Peripheral Artery Angioplasty Forecast
10.1.5 Middle East & Africa Peripheral Artery Angioplasty Forecast
10.2 Americas Peripheral Artery Angioplasty Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Peripheral Artery Angioplasty Forecast
10.2.2 Canada 麻豆原创 Peripheral Artery Angioplasty Forecast
10.2.3 Mexico 麻豆原创 Peripheral Artery Angioplasty Forecast
10.2.4 Brazil 麻豆原创 Peripheral Artery Angioplasty Forecast
10.3 APAC Peripheral Artery Angioplasty Forecast by Region (2026-2031)
10.3.1 China Peripheral Artery Angioplasty 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Peripheral Artery Angioplasty Forecast
10.3.3 Korea 麻豆原创 Peripheral Artery Angioplasty Forecast
10.3.4 Southeast Asia 麻豆原创 Peripheral Artery Angioplasty Forecast
10.3.5 India 麻豆原创 Peripheral Artery Angioplasty Forecast
10.3.6 Australia 麻豆原创 Peripheral Artery Angioplasty Forecast
10.4 Europe Peripheral Artery Angioplasty Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Peripheral Artery Angioplasty Forecast
10.4.2 France 麻豆原创 Peripheral Artery Angioplasty Forecast
10.4.3 UK 麻豆原创 Peripheral Artery Angioplasty Forecast
10.4.4 Italy 麻豆原创 Peripheral Artery Angioplasty Forecast
10.4.5 Russia 麻豆原创 Peripheral Artery Angioplasty Forecast
10.5 Middle East & Africa Peripheral Artery Angioplasty Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Peripheral Artery Angioplasty Forecast
10.5.2 South Africa 麻豆原创 Peripheral Artery Angioplasty Forecast
10.5.3 Israel 麻豆原创 Peripheral Artery Angioplasty Forecast
10.5.4 Turkey 麻豆原创 Peripheral Artery Angioplasty Forecast
10.6 Global Peripheral Artery Angioplasty Forecast by Type (2026-2031)
10.7 Global Peripheral Artery Angioplasty Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Peripheral Artery Angioplasty Forecast
11 Key Players Analysis
11.1 Medtronic, Inc.
11.1.1 Medtronic, Inc. Company Information
11.1.2 Medtronic, Inc. Peripheral Artery Angioplasty Product Offered
11.1.3 Medtronic, Inc. Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Medtronic, Inc. Main Business Overview
11.1.5 Medtronic, Inc. Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Peripheral Artery Angioplasty Product Offered
11.2.3 BD Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Information
11.3.2 Boston Scientific Corporation Peripheral Artery Angioplasty Product Offered
11.3.3 Boston Scientific Corporation Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Boston Scientific Corporation Main Business Overview
11.3.5 Boston Scientific Corporation Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Peripheral Artery Angioplasty Product Offered
11.4.3 Abbott Laboratories Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Cordis
11.5.1 Cordis Company Information
11.5.2 Cordis Peripheral Artery Angioplasty Product Offered
11.5.3 Cordis Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Cordis Main Business Overview
11.5.5 Cordis Latest Developments
11.6 Acotec
11.6.1 Acotec Company Information
11.6.2 Acotec Peripheral Artery Angioplasty Product Offered
11.6.3 Acotec Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Acotec Main Business Overview
11.6.5 Acotec Latest Developments
11.7 Biotronik
11.7.1 Biotronik Company Information
11.7.2 Biotronik Peripheral Artery Angioplasty Product Offered
11.7.3 Biotronik Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Biotronik Main Business Overview
11.7.5 Biotronik Latest Developments
11.8 Terumo Corporation
11.8.1 Terumo Corporation Company Information
11.8.2 Terumo Corporation Peripheral Artery Angioplasty Product Offered
11.8.3 Terumo Corporation Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Terumo Corporation Main Business Overview
11.8.5 Terumo Corporation Latest Developments
11.9 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd.
11.9.1 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Company Information
11.9.2 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Peripheral Artery Angioplasty Product Offered
11.9.3 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Main Business Overview
11.9.5 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Latest Developments
11.10 Cook Medical
11.10.1 Cook Medical Company Information
11.10.2 Cook Medical Peripheral Artery Angioplasty Product Offered
11.10.3 Cook Medical Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Cook Medical Main Business Overview
11.10.5 Cook Medical Latest Developments
11.11 Lepu Medical
11.11.1 Lepu Medical Company Information
11.11.2 Lepu Medical Peripheral Artery Angioplasty Product Offered
11.11.3 Lepu Medical Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Lepu Medical Main Business Overview
11.11.5 Lepu Medical Latest Developments
11.12 Zylox-Tonbridge Medical Technology Co., Ltd.
11.12.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
11.12.2 Zylox-Tonbridge Medical Technology Co., Ltd. Peripheral Artery Angioplasty Product Offered
11.12.3 Zylox-Tonbridge Medical Technology Co., Ltd. Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
11.12.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
11.13 LeoMed
11.13.1 LeoMed Company Information
11.13.2 LeoMed Peripheral Artery Angioplasty Product Offered
11.13.3 LeoMed Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 LeoMed Main Business Overview
11.13.5 LeoMed Latest Developments
11.14 LifeTech Scientific Corporation
11.14.1 LifeTech Scientific Corporation Company Information
11.14.2 LifeTech Scientific Corporation Peripheral Artery Angioplasty Product Offered
11.14.3 LifeTech Scientific Corporation Peripheral Artery Angioplasty Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 LifeTech Scientific Corporation Main Business Overview
11.14.5 LifeTech Scientific Corporation Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.